P
PCRX icon

Pitcairn’s Pacira BioSciences PCRX Stock Holding History

Pitcairn’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,693
Closed -$250K – 602
2022
Q3 		$250K Sell
4,693
-220
-4% -$12.2K 0.03% 488
2022
Q2 		$286K Buy
4,913
+235
+5% +$15.4K 0.03% 448
2022
Q1 		$357K Sell
4,678
-350
-7% -$23.3K 0.03% 459
2021
Q4 		$303K Buy
5,028
+7
+0.1% +$386 0.02% 516
2021
Q3 		$281K Buy
+5,021
New +$289K 0.02% 517

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Pitcairn's PCRX Position: Q4 2022 in Review

Pitcairn sold out of Pacira BioSciences (PCRX) in Q4 2022, closing a stake of 4,693 shares — an estimated $250K sold.

Pitcairn first reported a position in PCRX in Q3 2021 and held it in 5 quarters. The position peaked at $357K in Q1 2022. 273 funds tracked by Wall St. Rank hold PCRX as of Q4 2022.

  • Pitcairn reported no remaining Pacira BioSciences position as of Q4 2022 after selling out during the quarter.
  • Pitcairn sold 4,693 Pacira BioSciences shares in Q4 2022, an estimated $250K.
  • Pitcairn first reported a position in Pacira BioSciences in Q3 2021 and held it in 5 quarters.
  • Pitcairn's Pacira BioSciences position peaked at $357K in Q1 2022.
  • 273 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2022.

Based on Pitcairn's 13F filing for Q4 2022, filed 13 Feb 2023.